Hhlr Advisors LTD. Has $1.65 Million Position in Danaher Corporation $DHR

Key Points

• Hhlr Advisors LTD. has sold 5,053 shares of Danaher Corporation, reducing its holdings by 38.6% in the first quarter, now owning 8,026 shares valued at approximately $1.645 million.
• Danaher Corporation reported an EPS of $1.80 for the last quarter, exceeding expectations, while overall revenue grew by 3.4% compared to the previous year.
• Insider activity included the sale of 2,778 shares by Director Teri List, resulting in an 11.81% decrease in her holdings, and was conducted at an average price of $211.06 per share.

Hhlr Advisors LTD. cut its position in shares of Danaher Corporation (NYSE:DHR - Free Report) by 38.6% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 8,026 shares of the conglomerate's stock after selling 5,053 shares during the period. Hhlr Advisors LTD.'s holdings in Danaher were worth $1,645,000 as of its most recent SEC filing.

Several other large investors have also made changes to their positions in DHR. Nuveen LLC bought a new stake in Danaher in the first quarter worth approximately $833,941,000. GAMMA Investing LLC lifted its stake in shares of Danaher by 24,958.2% in the 1st quarter. GAMMA Investing LLC now owns 1,870,847 shares of the conglomerate's stock valued at $383,524,000 after purchasing an additional 1,863,381 shares during the last quarter. Two Sigma Advisers LP boosted its holdings in Danaher by 4,248.8% in the fourth quarter. Two Sigma Advisers LP now owns 1,639,500 shares of the conglomerate's stock worth $376,347,000 after purchasing an additional 1,601,800 shares in the last quarter. Invesco Ltd. increased its position in Danaher by 44.5% during the first quarter. Invesco Ltd. now owns 4,708,578 shares of the conglomerate's stock worth $965,259,000 after buying an additional 1,450,703 shares during the last quarter. Finally, Point72 Asset Management L.P. raised its holdings in Danaher by 460.6% during the fourth quarter. Point72 Asset Management L.P. now owns 1,348,544 shares of the conglomerate's stock valued at $309,558,000 after buying an additional 1,107,998 shares in the last quarter. Institutional investors own 79.05% of the company's stock.

Danaher Trading Down 0.2%

DHR stock traded down $0.47 during trading on Thursday, hitting $198.97. The company had a trading volume of 3,627,515 shares, compared to its average volume of 4,153,999. The firm has a 50-day moving average price of $201.94 and a 200-day moving average price of $199.49. Danaher Corporation has a 12 month low of $171.00 and a 12 month high of $279.90. The company has a quick ratio of 1.22, a current ratio of 1.62 and a debt-to-equity ratio of 0.32. The stock has a market cap of $142.47 billion, a price-to-earnings ratio of 42.33, a PEG ratio of 2.87 and a beta of 0.75.

Danaher (NYSE:DHR - Get Free Report) last released its earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 EPS for the quarter, beating the consensus estimate of $1.64 by $0.16. The company had revenue of $5.94 billion during the quarter, compared to analysts' expectations of $5.83 billion. Danaher had a return on equity of 10.70% and a net margin of 14.21%.The business's revenue for the quarter was up 3.4% on a year-over-year basis. During the same period last year, the firm earned $1.72 EPS. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. As a group, analysts predict that Danaher Corporation will post 7.63 earnings per share for the current year.

Insider Activity at Danaher

In related news, Director Teri List sold 2,778 shares of the business's stock in a transaction that occurred on Friday, August 22nd. The shares were sold at an average price of $211.06, for a total transaction of $586,324.68. Following the completion of the sale, the director directly owned 20,751 shares of the company's stock, valued at $4,379,706.06. The trade was a 11.81% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. 11.20% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

A number of equities research analysts have issued reports on DHR shares. Guggenheim reaffirmed a "buy" rating and set a $250.00 target price on shares of Danaher in a research report on Wednesday, July 23rd. Scotiabank upgraded shares of Danaher from a "sector perform" rating to a "sector outperform" rating and set a $275.00 price objective on the stock in a research note on Friday, July 11th. Barclays reiterated an "overweight" rating and issued a $225.00 price objective (up previously from $215.00) on shares of Danaher in a research report on Tuesday, June 24th. Evercore ISI lowered their price target on shares of Danaher from $230.00 to $226.00 and set an "outperform" rating on the stock in a report on Tuesday, July 8th. Finally, Deutsche Bank Aktiengesellschaft decreased their price objective on Danaher from $240.00 to $235.00 in a report on Thursday, June 5th. Seventeen equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat, the company currently has an average rating of "Moderate Buy" and an average price target of $246.35.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.